Clinical Trials Directory

Trials / Conditions / Immunoglobulin G4-Related Disease

Immunoglobulin G4-Related Disease

7 registered clinical trials studyying Immunoglobulin G4-Related Disease — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingStudy to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatri
NCT07222553
AmgenPhase 2
RecruitingA 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related
NCT07190196
SanofiPhase 3
Not Yet RecruitingStudy of the C5a/C5aR1 Axis in IgG4-associated Disease: a Potential Therapeutic Target
NCT06270524
Assistance Publique Hopitaux De MarseilleN/A
RecruitingInstitutional Registry of Rare Diseases
NCT06573723
Hospital Italiano de Buenos Aires—
UnknownDiagnostic and Prognostic Biomarkers for IgG4-related Disease.
NCT05901207
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau—
CompletedOpen Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants
NCT04520451
Principia Biopharma, a Sanofi CompanyPhase 2
RecruitingImmunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related
NCT05681975
Universidad Politecnica de Madrid—